Secondary amyloidosis risk factors: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 14: Line 14:
*** [[FMF]]
*** [[FMF]]
*** [[TNF Receptor associated periodic syndrome]] ([[TRAPS]])
*** [[TNF Receptor associated periodic syndrome]] ([[TRAPS]])
* [[Conditions]] associated with increased risk of secondary amyloidosis include:
*** Cryopyrin-associated periodic fever syndrome
*** Mevalonate kinase deficiency
** Tuberculosis
** Tuberculosis
** Leprosy
** Leprosy
Line 25: Line 26:
** Cystic fibrosis
** Cystic fibrosis
** Bronchiectasis
** Bronchiectasis
Kartagener syndrome
** Kartagener syndrome
Epidermolysis bullosa
** Epidermolysis bullosa
Injected drug abuse
** Injected drug abuse
Jejuno-ileal bypass
** Jejuno-ileal bypass
Paraplegia
** Paraplegia
Sickle cell anemia
** Sickle cell anemia
Immunodeficiency
** Immunodeficiency
Common variable immunodeficiency
** Common variable immunodeficiency
Cyclic neutropenia
** Cyclic neutropenia
Hyperimmunoglobulin M syndrome
** Hyperimmunoglobulin M syndrome
Hypogammaglobulinemia
** Hypogammaglobulinemia
Sex-linked agammaglobulinemia
** Sex-linked agammaglobulinemia
Human immunodeficiency virus/AIDS
** Human immunodeficiency virus/AIDS
Neoplasia
** Neoplasia
Adenocarcinoma
** Adenocarcinoma
Basal cell carcinoma
Basal cell carcinoma
Carcinoid tumor
Carcinoid tumor
Line 47: Line 48:
Hepatic adenoma
Hepatic adenoma
Hodgkin disease
Hodgkin disease
Mesothelioma
** Mesothelioma
Renal cell carcinoma
** Renal cell carcinoma
Sarcoma
** Sarcoma
Inflammatory Arthritis
** Inflammatory Arthritis
Adult-onset Still disease
** Adult-onset Still disease
Ankylosing spondylitis
** Ankylosing spondylitis
Juvenile idiopathic arthritis
** Juvenile idiopathic arthritis
Psoriatic arthropathy
** Psoriatic arthropathy
Reiter syndrome
** Reiter syndrome
Rheumatoid arthritis
** Rheumatoid arthritis
Gout
** Gout
Systemic Vasculitis
** Systemic Vasculitis
Antineutrophil cytoplasmic antibody-associated vasculitis
** Antineutrophil cytoplasmic antibody-associated vasculitis
Behc¸et disease
** Behcet disease
Giant cell arteritis
** Giant cell arteritis
Polyarteritis nodosa
** Polyarteritis nodosa
Polymyalgia rheumatica
** Polymyalgia rheumatica
Systemic lupus erythematosus
** Systemic lupus erythematosus
Takayasu arteritis
Takayasu arteritis
** Cryopyrin-associated periodic fever syndrome
** Mevalonate kinase deficiency
** Inflammatory Bowel Disease
** Inflammatory Bowel Disease
** Ulcerative colitis
** Ulcerative colitis

Revision as of 03:08, 30 October 2019

Secondary amyloidosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Secondary amyloidosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Secondary amyloidosis risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Secondary amyloidosis risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Secondary amyloidosis risk factors

CDC on Secondary amyloidosis risk factors

Secondary amyloidosis risk factors in the news

Blogs on Secondary amyloidosis risk factors

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Secondary amyloidosis risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]

Overview

The most potent risk factor in the development of secondary amyloidosis is a persistent inflammatory disorders.

Risk Factors

  • The most potent risk factor in the development of secondary amyloidosis is a persistent inflammatory disorders.[1]
  • chronic infections and inflammatory arthritis are among the most common risk factors.[2][3][4]
  • Other possible risk factors include:
  • Conditions Predisposing to Chronic Infections include:
    • Cystic fibrosis
    • Bronchiectasis
    • Kartagener syndrome
    • Epidermolysis bullosa
    • Injected drug abuse
    • Jejuno-ileal bypass
    • Paraplegia
    • Sickle cell anemia
    • Immunodeficiency
    • Common variable immunodeficiency
    • Cyclic neutropenia
    • Hyperimmunoglobulin M syndrome
    • Hypogammaglobulinemia
    • Sex-linked agammaglobulinemia
    • Human immunodeficiency virus/AIDS
    • Neoplasia
    • Adenocarcinoma

Basal cell carcinoma Carcinoid tumor Castleman disease Gastrointestinal stromal tumor Hairy cell leukemia Hepatic adenoma Hodgkin disease

    • Mesothelioma
    • Renal cell carcinoma
    • Sarcoma
    • Inflammatory Arthritis
    • Adult-onset Still disease
    • Ankylosing spondylitis
    • Juvenile idiopathic arthritis
    • Psoriatic arthropathy
    • Reiter syndrome
    • Rheumatoid arthritis
    • Gout
    • Systemic Vasculitis
    • Antineutrophil cytoplasmic antibody-associated vasculitis
    • Behcet disease
    • Giant cell arteritis
    • Polyarteritis nodosa
    • Polymyalgia rheumatica
    • Systemic lupus erythematosus

Takayasu arteritis

    • Inflammatory Bowel Disease
    • Ulcerative colitis
    • Crohn diseases
  • Others include:
    • Atrial myxoma
    • Inflammatory abdominal aortic aneurism
    • Retroperitoneal fibrosis
    • SAPHO (synovitis, acne, pustulosis, hyperostosis, and osteitis) syndrome
    • Sarcoidosis
    • Sinus histiocytosis with massive lymphadenopathy

References

  1. Koivuniemi, Riitta; Paimela, Leena; Suomalainen, Risto; Törnroth, Tom; Leirisalo-Repo, Marjatta (2009). "Amyloidosis is frequently undetected in patients with rheumatoid arthritis". Amyloid. 15 (4): 262–268. doi:10.1080/13506120802524676. ISSN 1350-6129.
  2. Blank, Norbert; Hegenbart, Ute; Dietrich, Sascha; Brune, Maik; Beimler, Jörg; Röcken, Christoph; Müller-Tidow, Carsten; Lorenz, Hanns-Martin; Schönland, Stefan O. (2018). "Obesity is a significant susceptibility factor for idiopathic AA amyloidosis". Amyloid. 25 (1): 37–45. doi:10.1080/13506129.2018.1429391. ISSN 1350-6129.
  3. van der Hilst, J. C. H.; Yamada, T.; Op den Camp, H. J. M.; van der Meer, J. W. M.; Drenth, J. P. H.; Simon, A. (2008). "Increased susceptibility of serum amyloid A 1.1 to degradation by MMP-1: potential explanation for higher risk of type AA amyloidosis". Rheumatology. 47 (11): 1651–1654. doi:10.1093/rheumatology/ken371. ISSN 1462-0324.
  4. Papa, Riccardo; Doglio, Matteo; Lachmann, Helen J.; Ozen, Seza; Frenkel, Joost; Simon, Anna; Neven, Bénédicte; Kuemmerle-Deschner, Jasmin; Ozgodan, Huri; Caorsi, Roberta; Federici, Silvia; Finetti, Martina; Trachana, Maria; Brunner, Jurgen; Bezrodnik, Liliana; Pinedo Gago, Mari Carmen; Maggio, Maria Cristina; Tsitsami, Elena; Al Suwairi, Wafaa; Espada, Graciela; Shcherbina, Anna; Aksu, Guzide; Ruperto, Nicolino; Martini, Alberto; Ceccherini, Isabella; Gattorno, Marco (2017). "A web-based collection of genotype-phenotype associations in hereditary recurrent fevers from the Eurofever registry". Orphanet Journal of Rare Diseases. 12 (1). doi:10.1186/s13023-017-0720-3. ISSN 1750-1172.